Home > Insider Trading > Filing (0001654954-24-003606)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1540159	Edesa Biotech Inc.	EDSA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1777962	Pardeep Nijhawan	C/O Edesa Biotech Inc. 100 Spy Court Markham A6 L3R 5H6	Chief Executive Officer	No	No	No	No
1780021	Pardeep Nijhawan Medicine Professional Corp	C/O Edesa Biotech Inc. 100 Spy Court Markham A6 L3R 5H6		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2024-03-25	5,000	$4.00	341,702	No	4	P	Indirect	Held by Pardeep Nijhawan Medicine Professional Corporation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Held by Pardeep Nijhawan Medicine Professional Corporation

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	107,810	Direct
Common Shares	32,609	Indirect	Held by The New Nijhawan Family Trust 2015
Common Shares	32,013	Indirect	Held by The Digestive Health Clinic Inc
Common Shares	53,104	Indirect	Held by 1968160 Ontario Inc

Footnotes

Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.